Drug Type Small molecule drug |
Synonyms Arbetuzole, Sabeluzole (USAN/INN), R 58735 + [1] |
Target |
Mechanism NMDA receptor antagonists(Glutamate [NMDA] receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC22H26FN3O2S |
InChIKeyIGMKTIJBFUMVIN-UHFFFAOYSA-N |
CAS Registry104383-17-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D05780 | Sabeluzole | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Phase 3 | US | - | - |
Alzheimer Disease | Phase 3 | JP | - | - |
Alzheimer Disease | Phase 3 | BE | - | - |
Alzheimer Disease | Phase 3 | - | - | |
Alzheimer Disease | Phase 3 | - | - | |
Diabetic Neuropathies | Phase 3 | - | - | |
Diabetic Neuropathies | Phase 3 | - | - |